Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma
Duerinck, J., Du Four, S., Bouttens, F., Andre, C., Verschaeve, V., Van Fraeyenhove, F., Chaskis, C., D’Haene, N., Le Mercier, M., Rogiers, A., Michotte, A., Salmon, I., Neyns, B.Language:
english
Journal:
Journal of Neuro-Oncology
DOI:
10.1007/s11060-017-2629-z
Date:
October, 2017
File:
PDF, 1.75 MB
english, 2017
File converter
More search results
More benefits 
